SOPHIA-ANTIPOLIS, France, March 03, 2022--Median Technologies files FDA 513(g) regulatory submission for iBiopsy® Lung Cancer Screening CADe/CADx Software as Medical Device.
SOPHIA ANTIPOLIS, France, March 01, 2022--Median Technologies to participate in the Cowen’s 42nd Annual Health Care Conference